Alphabet has been continuing to look for ways to cut costs while also stepping up investments in artificial intelligence.
The company has made various cuts to business organizations and has made leadership changes throughout the quarter.
Wall Street is expecting earnings of $1.45 per share and revenue of $75.97 billion, according to LSEG, formerly known as Refinitiv.Google's parent company is projected to show a return to double-digit revenue growth after four quarters of expansion mired inDuring the third quarter, Google made focused layoffs in various business organizations within the company.
Following the launch late last year of OpenAI's ChatGPT chatbot, Google has been racing to add generative AI technology to more products and is testing it within core search. Generative AI, which provides more creative and thorough answers to simple text queries, could potentially have a major effect on Google's search — and ads — business if people alter how they look for information online.at a recent all-hands meeting, hyping up the company's AI work.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Alphabet to report third-quarter earnings after the bellAlphabet has been continuing to look for ways to cut costs while also stepping up investments in artificial intelligence.
続きを読む »
Dow futures lift, Alphabet and Microsoft earnings in focusDow futures lift, Alphabet and Microsoft earnings in focus
続きを読む »
S&P 500 futures gain as Treasury yields fall further, Microsoft and Alphabet earnings loomJamie Chisholm is a markets reporter based in London.
続きを読む »
Microsoft, Alphabet earnings, Bitcoin, PMI data - what's moving marketsMicrosoft, Alphabet earnings, Bitcoin, PMI data - what's moving markets
続きを読む »
Dow futures rise as bond yields fall; Alphabet and Microsoft earnings in focusDow futures rise as bond yields fall; Alphabet and Microsoft earnings in focus
続きを読む »
Chevron, Hess, Roivant, Textainer, Microsoft, Alphabet, and More Stock Market MoversChevron will buy Hess in all-stock deal valued at $53 billion, Roche agrees to buy a developer of a drug for people suffering from inflammatory bowel disease...
続きを読む »